100 related articles for article (PubMed ID: 15173240)
21. Role of adenosine monophosphate deaminase-1 gene polymorphism in patients with congestive heart failure (influence on tumor necrosis factor-alpha level and outcome).
Gastmann A; Sigusch HH; Henke A; Reinhardt D; Surber R; Gastmann O; Figulla HR
Am J Cardiol; 2004 May; 93(10):1260-4. PubMed ID: 15135700
[TBL] [Abstract][Full Text] [Related]
22. Cardiac muscle AMP-deaminase from a 10-year-old male heterozygous for the AMPD1 C34T mutation.
Rybakowska I; Bakuła S; Klimek J; Milczarek R; Smolenski RT; Kaletha K
Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):453-6. PubMed ID: 20544536
[TBL] [Abstract][Full Text] [Related]
23. Association of improved cardiac function in donors with C34T mutation of the AMP deaminase 1 gene.
Yuen AH; Yacoub MH; Birks EJ; Kalsi KK; Johnson PH; Smolenski RT
Nucleosides Nucleotides Nucleic Acids; 2005; 24(4):275-7. PubMed ID: 16021915
[TBL] [Abstract][Full Text] [Related]
24. A novel 18-bp deletion mutation of the AMPD1 gene affects carcass traits in Qinchuan cattle.
He H; Liu X; Gu Y; Liu Y
Mol Biol Rep; 2010 Dec; 37(8):3945-9. PubMed ID: 20232158
[TBL] [Abstract][Full Text] [Related]
25. Identification of functional domains in AMPD1 by mutational analysis.
Gross M; Morisaki H; Morisaki T; Holmes EW
Biochem Biophys Res Commun; 1994 Dec; 205(2):1010-7. PubMed ID: 7802626
[TBL] [Abstract][Full Text] [Related]
26. Control of AMP deaminase 1 binding to myosin heavy chain.
Hisatome I; Morisaki T; Kamma H; Sugama T; Morisaki H; Ohtahara A; Holmes EW
Am J Physiol; 1998 Sep; 275(3):C870-81. PubMed ID: 9730972
[TBL] [Abstract][Full Text] [Related]
27. [Can mutation of the AMPD1 gene encoding human deaminase muscle muscle isozyme AMP be a prognostic marker of primary dilated cardiomyopathy?].
Kaletha K; Chodorowski Z; Nagel-Starczynowska G; Gazda M; Słomińska E
Postepy Biochem; 1999; 45(3):182-4. PubMed ID: 10761193
[No Abstract] [Full Text] [Related]
28. Association of C34T AMPD1 gene polymorphism with features of metabolic syndrome in patients with coronary artery disease or heart failure.
Safranow K; Czyzycka E; Binczak-Kuleta A; Rzeuski R; Skowronek J; Wojtarowicz A; Jakubowska K; Olszewska M; Loniewska B; Kaliszczak R; Kornacewicz-Jach Z; Ciechanowicz A; Chlubek D
Scand J Clin Lab Invest; 2009; 69(1):102-12. PubMed ID: 18855224
[TBL] [Abstract][Full Text] [Related]
29. Detecting novel SNPs and breed-specific haplotypes at calpastatin gene in Iranian fat- and thin-tailed sheep breeds and their effects on protein structure.
Aali M; Moradi-Shahrbabak M; Moradi-Shahrbabak H; Sadeghi M
Gene; 2014 Mar; 537(1):132-9. PubMed ID: 24401538
[TBL] [Abstract][Full Text] [Related]
30. Effects of AMPD1 gene C34T polymorphism on cardiac index, blood pressure and prognosis in patients with cardiovascular diseases: a meta-analysis.
Feng AF; Liu ZH; Zhou SL; Zhao SY; Zhu YX; Wang HX
BMC Cardiovasc Disord; 2017 Jul; 17(1):174. PubMed ID: 28673246
[TBL] [Abstract][Full Text] [Related]
31. Myoadenylate deaminase deficiency caused by alternative splicing due to a novel intronic mutation in the AMPD1 gene.
Isackson PJ; Bujnicki H; Harding CO; Vladutiu GD
Mol Genet Metab; 2005; 86(1-2):250-6. PubMed ID: 16040263
[TBL] [Abstract][Full Text] [Related]
32. Association between the C34T polymorphism of the AMPD1 gene and essential hypertension in Malaysian patients.
Nemati R; Lu J; Ramachandran V; Etemad A; Heidari M; Yahya MJ; Roozafzoon R; Ismail P
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323204
[TBL] [Abstract][Full Text] [Related]
33. A functional mutation in the AMPD1 promoter region affects promoter activity and breast meat freshness in chicken.
Yu S; Wang G; Liao J; Chen X
Anim Genet; 2021 Feb; 52(1):121-125. PubMed ID: 33226134
[TBL] [Abstract][Full Text] [Related]
34. Effect of adenosine monophosphate deaminase-1 C34T allele on the requirement for donor inotropic support and on the incidence of early graft dysfunction after cardiac transplantation.
Taegtmeyer AB; Breen JB; Rogers P; Johnson PH; Smith J; Smolenski RT; Banner NR; Yacoub MH; Barton PJ
Am J Cardiol; 2009 May; 103(10):1457-62. PubMed ID: 19427446
[TBL] [Abstract][Full Text] [Related]
35. AMPD1: a novel therapeutic target for reversing insulin resistance.
Cheng J; Morisaki H; Toyama K; Sugimoto N; Shintani T; Tandelilin A; Hirase T; Holmes EW; Morisaki T
BMC Endocr Disord; 2014 Dec; 14():96. PubMed ID: 25511531
[TBL] [Abstract][Full Text] [Related]
36. Molecular evolution and genetics of the Saitohin gene and tau haplotype in Alzheimer's disease and argyrophilic grain disease.
Conrad C; Vianna C; Schultz C; Thal DR; Ghebremedhin E; Lenz J; Braak H; Davies P
J Neurochem; 2004 Apr; 89(1):179-88. PubMed ID: 15030402
[TBL] [Abstract][Full Text] [Related]
37. Expression patterns of AMP-deaminase and cytosolic 5'-nucleotidase genes in human term placenta.
Roszkowska A; Klimek J; Kaletha K
Mol Cell Biochem; 2008 Apr; 311(1-2):249-51. PubMed ID: 18165923
[TBL] [Abstract][Full Text] [Related]
38. Molecular basis of AMP deaminase deficiency in skeletal muscle.
Morisaki T; Gross M; Morisaki H; Pongratz D; Zöllner N; Holmes EW
Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6457-61. PubMed ID: 1631143
[TBL] [Abstract][Full Text] [Related]
39. Haplotype structure and allele frequencies of CYP2B6 in a Korean population.
Cho JY; Lim HS; Chung JY; Yu KS; Kim JR; Shin SG; Jang IJ
Drug Metab Dispos; 2004 Dec; 32(12):1341-4. PubMed ID: 15383491
[TBL] [Abstract][Full Text] [Related]
40. AMPD1 gene mutation in congestive heart failure: new insights into the pathobiology of disease progression.
Feldman AM; Wagner DR; McNamara DM
Circulation; 1999 Mar; 99(11):1397-9. PubMed ID: 10086958
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
